Report on the 11th Neuromuscular Translational Research Conference in April 2018
More than 200 delegates from around the world attended the conference held on 19th and 20th April in Fitzwilliam College, […]
Continue Reading
More than 200 delegates from around the world attended the conference held on 19th and 20th April in Fitzwilliam College, […]
Continue ReadingNantes, France – May 22th, 2018. InFlectis BioScience SAS, a drug discovery company committed to the development of innovative therapeutics […]
Continue ReadingResearchers have found that disease progression in Charcot-Marie-Tooth type 1A (CMT1A) patients reaches a critical point at age 50, after which […]
Continue ReadingDr Shevchuk and his team have established a method that allows them to study the effects of mutations in the […]
Continue ReadingBioPontis Alliance for Rare Diseases today announces receipt of a large three year donation from the prestigious Baillet Latour Fund […]
Continue ReadingImportant implications for experimental trials in Neuromuscular Diseases 9 November 2015 – http://www.ucl.ac.uk/ion/articles/news/20151106 A UCL Institute of Neurology study published […]
Continue ReadingLast Updated: Thursday 12th November, 2015